$0.327
-0.005 (-1.66%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
HRTX Prediction & Forecast by Similar Chart Analysis
Alphio's HRTX stock price prediction model matches the current Heron Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.33 (-0.05%). The 1-week path is $0.32 (-0.97%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Heron Therapeutics Inc Stock?
Heron Therapeutics Inc is not a good buy right now due to significant financial losses and legal challenges. The current price is $0.3266, and the company reported a net loss of $5.49 million in Q2 2026, which is a substantial increase from the previous year's loss of $2.38 million. Additionally, the stock has seen a year-to-date change of -74.08%, indicating a severe decline in value. The primary risk is the invalidation of key patents related to its main product, CINVANTI, which could lead to increased competition from generics and further financial instability.
HRTX stock price ended at $0.33 on Friday, after losing -1.66%
Heron Therapeutics Inc (HRTX) last closed at $0.3266, losing -1.66%. These facts feed the 1-day and 1-week HRTX price prediction above.
Analyst Consensus
Heron Therapeutics Inc (HRTX): 11 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Heron Therapeutics Inc (HRTX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches HRTX, ranked by similarity.
Seasonality analysis for HRTX
Historically the probability of a positive August return for HRTX is 38.10%. February offers the highest probability of a positive month at 75.86%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for HRTX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $2.17 | $2.24 | $2.47 | +584.96% |
| Sep 2026 | $2.01 | $2.31 | $2.35 | +608.38% |
| Oct 2026 | $1.91 | $2.22 | $2.53 | +580.32% |
| Nov 2026 | $2.29 | $2.32 | $2.43 | +610.32% |
| Dec 2026 | $1.66 | $1.91 | $2.09 | +484.76% |
In 2026, Heron Therapeutics Inc (HRTX) is projected to range from $1.66 to $2.53.
Heron Therapeutics Inc 2026 monthly forecast
In Aug 2026, Heron Therapeutics Inc is projected to average $2.24, with a low of $2.17 and high of $2.47.
In Sep 2026, Heron Therapeutics Inc is projected to average $2.31, with a low of $2.01 and high of $2.35.
In Oct 2026, Heron Therapeutics Inc is projected to average $2.22, with a low of $1.91 and high of $2.53.
In Nov 2026, Heron Therapeutics Inc is projected to average $2.32, with a low of $2.29 and high of $2.43.
In Dec 2026, Heron Therapeutics Inc is projected to average $1.91, with a low of $1.66 and high of $2.09.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.